Pioglitazone Effect on Clinical Outcome and Inflammatory Response in patients with type 2 diabetes mellitus and COVID-19: A Randomized Clinical Trial

<h3>Background</h3><p dir="ltr">The pandemic of COVID-19 infection has emerged as a rapidly spreading communicable disease across the globe. Patients with diabetes mellitus are at a higher risk of mortality from COVID-19, mainly due to the chronic. inflammatory state asso...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Eman Elmekaty (14777932) (author)
مؤلفون آخرون:	Khaled Baagar (7487690) (author), Amin Jayyousi (3158868) (author), Thamer Alessa (10534630) (author), Muhammad Abdul-Ghani (4707436) (author), Mohamed Abu-Farha (25322) (author), Ali Senosi Omrani (18505373) (author), Jose Ceruto (18505376) (author), Mohammad Khair Hamad (18505379) (author), Muhammad Zaka-Ul Haq (18505380) (author), Abdul Safi, Bassem Alhariri (18505381) (author), Manish Barman (18505384) (author), Alaaeldin Abdelmajid (12535542) (author), Pioglitazone and COVID-19 study group (18505385) (author)
منشور في:	2024
الموضوعات:	Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Pharmacology and pharmaceutical sciences Coronavirus COVID-19 Diabetes Mellitus Pioglitazone RCT Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Pioglitazone Effect on Clinical Outcome and Inflammatory Response in patients with type 2 diabetes mellitus and COVID-19: A Randomized Clinical Trial

مواد مشابهة